Topic: Eye Care
"The results of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, supported by the National Institutes of Health (NIH), show promising results in slowing the advancement of diabetic retinopathy and its effect on vision," noted HealthNewsDigest. "The study examined adults who had Type 2 diabetes for an average of 10 years and were evaluated after different types of treatments of control of blood sugar, lipids and blood pressure. Intensive blood sugar control, compared with standard blood sugar control, decreased the progression of diabetic retinopathy by about one-third, from 10.4 percent to 7.3 percent, over four years."
